# A Clinical Study of ONO-1110 in Patients With Hunner Type Interstitial Cystitis

> **NCT06752603** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Ono Pharmaceutical Co., Ltd.** · enrollment: 50 (estimated)

## Conditions studied

- Hunner Type Interstitial Cystitis

## Interventions

- **DRUG:** ONO-1110
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06752603
- **Lead sponsor:** Ono Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-04-02
- **Primary completion:** 2026-09
- **Final completion:** 2026-11
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06752603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06752603, "A Clinical Study of ONO-1110 in Patients With Hunner Type Interstitial Cystitis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06752603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*